Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-80,409
Closed -$2.42M 844
2020
Q4
$2.42M Buy
+80,409
New +$2.37M 0.05% 333
2020
Q3
Sell
-70,100
Closed -$1.81M 354
2020
Q2
$1.81M Buy
+70,100
New +$1.86M 0.04% 236
2015
Q3
Sell
-765,074
Closed -$17.1M 580
2015
Q2
$17.1M Sell
765,074
-152,571
-17% -$3.65M 0.3% 95
2015
Q1
$22M Buy
917,645
+131,473
+17% +$3.26M 0.47% 54
2014
Q4
$20.8M Sell
786,172
-17,454
-2% -$448K 0.36% 77
2014
Q3
$19.5M Sell
803,626
-152,538
-16% -$3.57M 0.34% 89
2014
Q2
$24.9M Buy
+956,164
New +$24.4M 0.16% 62

Other funds holding EXC

UBS O'Connor's EXC Position: Q1 2021 in Review

UBS O'Connor sold out of Exelon (EXC) in Q1 2021, closing a stake of 80,409 shares — an estimated $2.42M sold.

UBS O'Connor first reported a position in EXC in Q2 2014 and held it in 7 quarters. The position peaked at $24.9M in Q2 2014. 922 funds tracked by Wall St. Rank hold EXC as of Q1 2021.

  • UBS O'Connor reported no remaining Exelon position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 80,409 Exelon shares in Q1 2021, an estimated $2.42M.
  • UBS O'Connor first reported a position in Exelon in Q2 2014 and held it in 7 quarters.
  • UBS O'Connor's Exelon position peaked at $24.9M in Q2 2014.
  • 922 funds tracked by Wall St. Rank held Exelon as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.